Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$15.17 USD
+0.01 (0.07%)
Updated Jun 27, 2024 04:00 PM ET
After-Market: $15.18 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-1.01 | -15.46% |
Earnings Summary
For their last quarter, Arcus Biosciences (RCUS) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.97 per share. This reflects a positive earnings surprise of 94.85%. Look out for RCUS's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$1.01 per share, reflecting a year-over-year increase of 2.88%.
Earnings History
Price & Consensus
Zacks News for RCUS
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
RCUS: What are Zacks experts saying now?
Zacks Private Portfolio Services